Quantcast
Microchip Uses Nanotechnology To Cheaply Easily Diagnose

Microchip Uses Nanotechnology To Cheaply, Easily Diagnose Type-1 Diabetes

redOrbit Staff & Wire Reports - Your Universe Online Researchers from the Stanford University School of Medicine have developed an inexpensive and portable new device that uses nanotechnology to diagnose type-1 diabetes – a breakthrough...

Latest Autoimmunity Stories

2014-07-21 12:24:51

DANVERS, Mass., July 21, 2014 /PRNewswire/ -- The Scleroderma Foundation is preparing for 600 people from around the world to attend its National Patient Education Conference later this week in Southern California. This unique educational event will be held at the Anaheim Marriot Friday, July 25, through Sunday, July 27. The conference focuses on scleroderma, a mysterious, and sometimes fatal, autoimmune disease that causes a person's body to attack itself by creating too much...

2014-07-18 23:02:00

Annual conference provides groundbreaking approaches to treating patients with interrelated autoimmune conditions. Malvern, PA (PRWEB) July 18, 2014 The inaugural Interdisciplinary Autoimmune Summit (IAS) brought together more than 150 gastroenterologists, rheumatologists, dermatologists, immunologists, internists, industry, and other allied healthcare professionals at The Mirage, Las Vegas, NV, June 20-22, 2014. "IAS 2014 was a wonderful opportunity to meet and discuss best...

2014-07-16 08:29:40

HERZLIYA, Israel, July 16, 2014 /PRNewswire/ -- XTL Biopharmaceuticals Ltd. (NASDAQ: XTLB, TASE: XTL) ("XTL" or the "Company"), a clinical-stage biopharmaceutical company focused on the acquisition, development and commercialization of pharmaceutical products for the treatment of unmet clinical needs, announced today that an overview of its hCDR1 peptide to treat patients with systemic lupus erythematosus (SLE) is included in an article titled, Novel Approaches to the Development of...

2014-07-16 08:28:17

PORTLAND, Ore., July 16, 2014 /PRNewswire-USNewswire/ -- Thirteen scientists received a total of $1.05 million in funding from the National Psoriasis Foundation for projects that aim to identify new treatments and a cure for psoriasis--an autoimmune disease that appears on the skin, affecting 7.5 million Americans--and psoriatic arthritis--an inflammatory arthritis that affects the joints and tendons, occurring in up to 30 percent of people with psoriasis. Learn more about the NPF research...

2014-07-16 08:28:09

--Novel Biologic Targets Innovative New Mechanism in Lupus-- SEATTLE, July 16, 2014 /PRNewswire/ -- Resolve Therapeutics, LLC announced today the initiation of a multi-dose, one month phase 2 clinical study with its lead compound RSLV-132 in systemic lupus erythematosus (SLE). http://photos.prnewswire.com/prnvar/20140715/127341 Following the successful completion of it phase 1 single dose safety study with RSLV-132, Resolve recently initiated a phase 2 study in lupus patients. The...

2014-07-15 00:20:40

SAN DIEGO, July 14, 2014 /PRNewswire/ -- aTyr Pharma, an innovative rare disease therapeutics enterprise announced today, the scientific publication of a splice variant of a tRNA synthetase in association with a rare muscle disease. This article, published in the Journal of Biological Chemistry, demonstrated novel findings relative to Physiocrine proteins, that include extracellular functions derived from the tRNA synthetase gene family. These data further highlight the potential...

2014-07-14 12:23:03

Cincinnati Children's Hospital Medical Center New research in Nature Genetics identifies a novel genetic and molecular pathway in the esophagus that causes eosinophillic esophagitis (EoE), opening up potential new therapeutic strategies for an enigmatic and hard-to-treat food allergy. EoE is a chronic inflammatory disorder of the esophagus. The condition is triggered by allergic hypersensitivity to certain foods and an over-accumulation in the esophagus of white blood cells called...

2014-07-11 10:08:10

University of Copenhagen – The Faculty of Health and Medical Sciences A number of studies suggest that children delivered by Caesarean section have a different intestinal flora than children delivered by natural birth. But it is still unknown why this is the case and what it means for the immune system. Researchers from the Faculty of Health and Medical Sciences therefore decided to scrutinize the impact of birth on the development of the immune system in a study of newborn mouse pups....

2014-07-08 12:28:28

Strengthens Collaboration between the Nation's Lupus Research Organizations NEW YORK, July 8, 2014 /PRNewswire/ -- The Lupus Research Institute (LRI) today announced that Team Life Without Lupus(®) is joining the Alliance for Lupus Research (ALR) fundraising program Walk with Us to Cure Lupus in New York City to help raise funds for lupus research. To that end, 100% of all funds raised by LRI's Team Life Without Lupus will go towards lupus research. The LRI and ALR are...

2014-07-07 23:05:55

The Autoimmunity Bible & Norton Protocol is a new product created by Julia Liu and is a system designed for people suffering from and wanting to cure for good their autoimmune disorders. A complete review on the site Vinamy.com points out whether or not this program is effective. Seattle, WA (PRWEB) July 07, 2014 One of the last remaining mysteries know to modern medicine is the presence of the autoimmune disease, a blanket term applied for specific ailments which are caused by a...


Word of the Day
penuche
  • A fudgelike confection of brown sugar, cream or milk, and chopped nuts.
'Penuche' is a variant of 'panocha,' a coarse grade of sugar made in Mexico. 'Panocha' probably comes from the Spanish 'panoja, panocha,' ear of grain.
Related